SCHEMBL9627133

SCHEMBL9627133

CCCOC1=C(CC)C(=O)c2ccccc2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.46
▸ MAPT P10636 10/20 0.45
▸ ALDH1A1 P00352 9/20 0.45
▸ LMNA P02545 8/20 0.45
▸ KDM4E B2RXH2 7/20 0.45
▸ HPGD P15428 6/20 0.45
▸ CDC25B P30305 4/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ TDP1 Q9NUW8 4/20 0.45
▸ POLB P06746 3/20 0.45
▸ BLM P54132 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ CDC25A P30304 2/20 0.45
▸ MAP2K7 O14733 1/20 0.45
▸ GMNN O75496 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9627657 0.91 PTPN1 (0.53) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL9627480 0.89 PTPN1 (0.44) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL9627536 0.89 CDC25B (0.53) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL9641989 0.88 CDC25B (0.52) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL9629370 0.84 PTPN1 (0.50) PTPN1MAPTALDH1A1TDP1THRB
SCHEMBL9627555 0.83 CDC25B (0.57) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL9628254 0.81 MAPT (0.65) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL9628126 0.80 CDC25B (0.49) PTPN1MAPTALDH1A1LMNAKDM4E
SCHEMBL30004167 0.80 FGFR1 (0.57) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL5820931 0.80 FGFR1 (0.57) MAPTALDH1A1LMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 — — US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 — — US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 — — US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 — — US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 — — US disclosed
Send feedback